Related Experiment Videos
Prediction of morbidity and mortality from cardiac allograft vasculopathy
1Cardiac Transplant Research, Heart Failure Center & Div. of Circ. Phys., Columbia University College of Physicians & Surgeons, New York, N.Y. 10032, USA.
Zeitschrift Fur Kardiologie
|January 11, 2001
Insights
Assessing cardiac allograft vasculopathy involves evaluating nonimmunological and immunological risk factors. Parameters include epicardial coronary vessels, microvasculature, and left ventricular function for clinical event assessment.
Area of Science:
- Cardiology
- Transplantation Immunology
Background:
- Cardiac allograft vasculopathy (CAV) is a major cause of late graft failure.
- Early detection and risk stratification are crucial for patient outcomes.
Purpose of the Study:
- To identify key parameters for assessing clinical events in cardiac allograft vasculopathy.
- To explore the utility of nonimmunological and immunological factors in CAV assessment.
Main Methods:
- Review of parameters related to CAV.
- Analysis of factors including immunological and nonimmunological risk factors.
- Evaluation of epicardial coronary vessels, microvasculature, and left ventricular function.
Main Results:
- Parameters assessing CAV include both immunological and nonimmunological risk factors.
- Assessment of epicardial coronary vessels, microvasculature, and left ventricular function are relevant.
- These parameters aid in evaluating clinical events associated with CAV.
Conclusions:
- Multiple parameters are valuable for assessing clinical events in cardiac allograft vasculopathy.
- A comprehensive approach utilizing immunological, nonimmunological, and functional parameters improves CAV assessment.
Abstract:
For assessing clinical events associated with cardiac allograft vasculopathy, parameters relating to nonimmunological or immunological risk factors, epicardial coronary vessels, microvasculature, or left ventricular function may be utilized.